Nashville, Tennessee — According to state and local economic development sources, Tennessee Oncology plans to invest $236,000.00 to build out 6,442 square feet of new space in Nashville. The company plans to occupy the new space at 397 Wallace Rd in Nashville, on or about July 1, 2023. According to the company website Tennessee Oncology is one of the nations largest community-based cancer care specialists and home to one of the leading clinical trial networks in the country. Established 1976 in Nashville, Tennessee Oncologys mission remains unchanged: To provide access to high quality cancer care and the expertise of clinical research for all patients at convenient locations within their community and close to their home. To this day, our growing network of physicians and number of locations is based on this mission. In 2018, Tennessee Oncology joined OneOncology, a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the United States, as a founding practice partner. Physicians specializing in gynecologic oncology, palliative care, radiation oncology, and health psychology comprise our group. Tennessee Oncology provides a full range of diagnostic services, including oncology specific expertise in PET/CT and laboratory services. Clinic locations provide on-site chemotherapy treatments so that patients receive care in their community and close to their home. Our physicians utilize the latest in molecular diagnostics and profiling to choose treatments specific to the genetics of your cancer. Oncology research is the largest area of new drug development. Self -administered medications, those taken by mouth or injected by the patient, comprise approximately 40% of these investigative medications. Tennessee Oncologys in house pharmacy, Park Pharmacy, stocks oncology and hematology medications not readily available at community retail pharmacies. A URAC accredited Specialty Pharmacy, Park provides insurance and benefits investigation, prior authorization services for insurance coverage, co-pay assistance through manufacturer or foundation programs, extensive medication education, and access to a pharmacist 24 hours a day, 7 days a week.

To learn more about Tennessee Oncology, visit http://tnoncology.com/

Company Contact:
Jeffrey Patton, Chief Executive Officer
https://www.linkedin.com/in/jeffrey-patton-39a9a45/
877-836-6662

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.